Stock to buy: Jefferies lists 10 reasons to buy its top CRDMO pick Sai Life Sciences
Analysis of this story by et_markets · 12 Mar 2026, 11:25 AM IST (about 2 months ago)
AI Analysis
Analyst recommendations often drive short-term stock movements, especially for mid-cap companies. The broader market has seen mixed signals recently, with some days of significant falls and others of gains, making stock-specific positive news more impactful.
Trading Insight
Look for accumulation in Sai Life Sciences, potentially on dips, with a bullish bias given the strong analyst endorsement.
Quick check: NIFTY neutral, BANKNIFTY neutral.
Key Evidence
- •Jefferies initiated coverage on Sai Life Sciences with a 'Buy' rating.
- •Target price set at Rs 1,300.
- •Key investment drivers cited include integrated 'follow-the-molecule' model, healthy pipeline, global presence, and clean balance sheet.
- •Brokerage projects significant upside potential for the company.
- •Risk flag: Broader market volatility could dampen individual stock performance.
Affected Stocks
People in this Story
J
Sources and updates
Original source: et_markets
Published: 12 Mar 2026, 11:25 AM IST
Last updated on Anadi News: 12 Mar 2026, 11:39 AM IST
AI-powered analysis by
Anadi Algo News